Featured Research

from universities, journals, and other organizations

Ovarian cancer finding may be a 'win-win' for at-risk women who wish to have a family

Date:
April 8, 2011
Source:
Oregon Health & Science University
Summary:
New research suggests that a layer of cells, which serve as the "breeding ground" for ovarian cancer, may be removed yet allow the women to have children. This would be a vast improvement over the current prevention strategy for women at high risk for ovarian cancer: Removal of the ovaries entirely.

Researchers at Oregon Health & Science University's Oregon National Primate Research Center may have good news for women at high-risk for ovarian cancer who also want to have children. The research suggests that a layer of cells, which serve as the "breeding ground" for ovarian cancer, may be removed yet allow the women to have children. This would be a vast improvement over the current prevention strategy for women at high risk for ovarian cancer: Removal of the ovaries entirely.

The research is published in the current online edition of the journal Human Reproduction.

The new treatment approach being tested at OHSU focuses on a layer of cells that surround the ovaries called ovarian surface epithelium. These cells, which have no known function, are where ovarian cancer takes root. To conduct the research, scientists washed away the ovarian surface epithelium in healthy female monkeys through minimally invasive surgery.

Following the procedure, the animals were closely observed to determine if removal of the cells changed function of the ovaries themselves. This observation revealed that the animals' ovaries produced eggs at a normal rate, as well as estrogen and progesterone in normal cyclic patterns. The procedure did not appear to affect the health of the ovaries or the overall health of the animals.

Because women with a family history of the disease are at a much higher risk for ovarian cancer themselves, many of these women choose to have their ovaries removed as a precaution. Of course for young women, this can be a major quality of life issue as the treatment prevents future childbirth and removes the primary source of a woman's estrogen.

"While additional studies are necessary, this procedure suggests that we may have found a much less invasive strategy for preventing ovarian cancer in high-risk women while at the same time maintaining fertility," said Jay Wright, Ph.D., a scientist in the Division of Reproductive Sciences at the Oregon National Primate Research Center. "This is a key finding in monkeys because their reproductive system is so similar to the human female reproductive system."

The National Institute of Child Health and Human Development and the National Center for Research Resources which are components of the National Institutes of Health, and the OHSU Foundation funded this research.

About Ovarian Cancer

  • Each year, approximately 20,000 women in the United States are diagnosed with ovarian cancer.
  • Among women in the United States, ovarian cancer is the eighth most common cancer and the fifth leading cause of cancer death.
  • In 2010, there were 21,880 new cases ovarian cancer diagnosed in the United States and 13,850 deaths. (source CDC)

Story Source:

The above story is based on materials provided by Oregon Health & Science University. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. W. Wright, T. Pejovic, L. Jurevic, C. V. Bishop, T. Hobbs, R. L. Stouffer. Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement. Human Reproduction, 2011; DOI: 10.1093/humrep/der061

Cite This Page:

Oregon Health & Science University. "Ovarian cancer finding may be a 'win-win' for at-risk women who wish to have a family." ScienceDaily. ScienceDaily, 8 April 2011. <www.sciencedaily.com/releases/2011/04/110407132612.htm>.
Oregon Health & Science University. (2011, April 8). Ovarian cancer finding may be a 'win-win' for at-risk women who wish to have a family. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110407132612.htm
Oregon Health & Science University. "Ovarian cancer finding may be a 'win-win' for at-risk women who wish to have a family." ScienceDaily. www.sciencedaily.com/releases/2011/04/110407132612.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins